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A Comprehensive Analysis of the 
Current Status and Unmet Needs  
in Kidney Transplantation in 
Southeast Asia
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1 Division of Nephrology, Faculty of Medicine, Department of Internal Medicine, Khon Kaen University, Khon Kaen,  
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To address the unmet needs in the face of a growing demand for end-stage renal failure 
management and kidney transplantation in Asia, we have conducted a critical analysis of 
published literature and national registries to evaluate clinical outcomes and the rates of 
organ donation in Southeast Asia and the challenges facing these regions with regards 
to regulation, choice of donor source, and funding. Based on the available data, sug-
gestions are proposed for an advancement of rates of organ donation and access, with 
emphasis on improved regulation and public education.
Keywords: organ donation, organ access, transplant policy, transplant law, kidney transplantation, health 
financing, donor compensation, kidney graft survival
iNTRODUCTiON
Organ transplantation (tx) is the treatment of choice for patients who suffer from end organ failure 
(1–3). With the increasing morbidity of organ failure due to the evolution of dietary and environ-
mental triggers, there is increasing pressure on the tx wait-lists that do not match the growth in available 
transplants. Improved health care accessibility and longevity also result in a growing population 
of individuals with end-stage renal disease (ESRD) (4, 5). Global tx activity in 2014 rose by 1.81% 
from 2013, which only meet ~ 10% of the global need for new organs (6). Asia is the most populated 
region in the world but, conversely, has the lowest rate of organ tx and the greatest growth rate for 
numbers of people entering chronic and end-stage organ failure (6). In 2014, in Southeast Asia, the 
rate of organ tx was 3.8 patients per million population (ppmp), compared to 31.6 ppmp in the US 
and 27.9 ppmp in Europe (6). This discrepancy in morbidity and organ availability and vast social, 
economic, and political diversity in the region has fostered organ trafficking in Southeast Asia (7). 
The inequities in health care accessibility are further complicated in this region by epidemiological 
pressures (8), policies on health care financing (9), and medical technology diffusion (10). To update 
the impact of these changes on tx provisions in Southeast Asia, we reviewed the tx rate, the burden 
of organ shortage, organ access, legislation framework, reimbursement, and clinical outcome data in 
this continent. We also examined the causes of the unmet needs for organ tx in this region, compared 
to similar data from the US as an international benchmark, with a view to understanding regional 
pressures that can help to improve access and outcomes of organ transplantation in this region.
We searched the PUBMED electronic database for English-language peer-reviewed reports, 
computerized databases, government reports, dissertations, and online national registries in 
each of the countries in Southeast Asia. Relevant articles between 1956 and 2016 were reviewed 
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for additional information as the databases and registries may 
not provide complete data due to the voluntary nature of their 
reporting.
The Southeast Asian continent has several strata of countries 
with wide variations in the gross national income per capita sta-
tistics from the World Bank (11) and human development index 
(HDI) from United Nations Development Program (12, 13). HDI 
is a composite index of the achievement in longevity, education, 
and income, which are three key dimensions of human develop-
ment (13–15). There is evidence for an association of organ tx 
access with national income and HDI (10). Thus, we also provide 
income and HDI at a glance before exploring tx services in dif-
ferent countries in this region.
The Southeast Asian region has been defined following the 
division of geographic areas as assessed by the United Nations 
Statistic Division revised September 26th, 2016 (16). Southeast 
Asia consists of 11 members (Figure 1) ranked from high-income 
economies like Singapore and Brunei Darussalam to low-income 
economies like Cambodia, Laos, Myanmar, and Timor-Leste. 
Singapore is in the very high HDI while Myanmar is in the 
lowest. The trend of increased incidence of treated ESRD in 
developing countries is marked in this region (Figure 2). From 
the 2015 United States Renal Data System Annual data report, the 
greatest proportional increases in the incidence of treated ESRD 
over the interval from 2000/1 to 2012/13 were seen in the fol-
lowing countries (8): Thailand (1,210%), Philippines (185%), and 
Malaysia (176%). The reasons are because of improved standards 
of clinical care (17, 18), increased access to medical treatment (9), 
and longer life expectancy (19).
SiNGAPORe
Organ Access, Legislation, and 
Reimbursement
Singapore is fully equipped for serving transplantation needs 
for its residents. It has a very high HDI and also has the highest 
incidence of treated ESRD (Figure  2). Though Singapore was 
not listed above for the largest proportional increase in treated 
ESRD in the region, as it has already reached a high level of 
>300  ppmp-treated ESRD in the year 2013, which is close to 
the figure of 363.1 ppmp-treated ESRD in the US (8). The rate 
of kidney tx reached a peak at 24.1 ppmp in 2006, but has stayed 
stable (Figure 2), due to a limitation in the rate of deceased dona-
tion. Despite the revision of the organ donation law in 2009, the 
deceased donation rate runs between 3 and 6 ppmp in Singapore 
(Table 1; Figure 3), versus a comparison of 25–26 ppmp in the 
US (Figure 3). Thus, the tx waiting list numbers of patients in 
Singapore continues to rise.
Singapore is the only country in Asia enabling presumed 
consent under The Human Organ Transplant Act (HOTA), 
enacted in 1987 (20–22). This act allows for the kidneys of 
all non-Muslim Singapore citizens and permanent residents 
between the ages of 21–60 without mental disorders, to be 
donated in the event of accidental death for tx unless they explic-
itly opt out. HOTA increased the deceased donor kidney tx rate 
from an average of 4.7 per annum (approximately 2 ppmp per 
annum) between 1970 and 1987 to an average of 40.8 per annum 
(approximately 11.4 ppmp per annum) between 1988 and 2004 
(23). To expand the eligible donor pool, HOTA was amended 
in January 2004 to also allow transplantation of liver, heart, and 
cornea (24, 25). This bill extended organ donation from donors 
with non-accidental causes of death and added the regulation for 
organ donation from living (both related and unrelated) organ 
donors. It was later amended in August 2008 to include Muslim 
organ donors, and then in March 2009 to remove the upper age 
limit for potential deceased donors, paired kidney exchange 
permission, increased penalties for organ trading, and donor 
compensation (21, 22). Before the availability of HOTA, the 
Singapore government utilized the Medical Therapy, Education, 
and Research Act, which was the opt-in donation law enacted 
in 1973 (20–22). This law allowed any person to donate organs 
in the event of death for the purpose of treatment, education, or 
research (20–22). The Singapore government has also provided 
the criteria for determining death by brain death or cardiac death 
under The Interpretation Act (Certification and Determination 
of Death) (24).
Singapore established the National Organ Transplant Unit in 
1970. This body regulates the national organ waiting list and main-
tains the national registry of recipients and donors (26). To date, 
kidney, liver, lungs, heart, corneas, skin, bone, and bone marrow 
tx are available in both public and private hospitals. Living donor 
tx are performed in both the public and private hospitals while 
deceased donor tx are carried out only in the public hospitals 
(27). Singaporeans receiving overseas tx return to follow-up in 
Singapore and are registered in national renal registry database if 
they have a functioning tx after 30 days (27).
Singapore has an excellent health financing system, where the 
public and the private sector work in cooperation for affordable 
health care (28) that utilizes 4.9% of GDP (Table 2), three times 
lower than the US, which uses 17.1% of the GDP for health care 
(15). Singaporean employees contribute to individual medical 
saving accounts, the Medisave program, which is a national 
healthcare savings scheme to afford payment for personal and 
family hospitalization costs. The Ministry of Health subsidizes 
lower- and middle-income patients for dialysis costs as well as 
selected immunosuppressive drugs in public healthcare institu-
tions (29). Those patients also use the Medisave benefits to pay for 
their dialysis or immunosuppressive drugs after the government 
subsidies (28–30). To protect the poor, low-income patients have 
a right to apply for and get additional subsidies from the gov-
ernment, and welfare or charity organizations (29), such as the 
National Kidney Foundation, the Kidney Dialysis Foundation, 
and the Khoo Foundation.
Tx Outcomes
The unadjusted 1- and 5-year kidney graft survival for living donor 
are excellent at 98.1 and 95.3%, as reported by the Singapore Renal 
Registry, compared to 95.1 and 80.2% from the US, as reported by 
Organ Procurement and Transplantation Network (OPTN) (31, 
32). Selection bias and lower patients’ comorbidities are likely causes 
to support these excellent results. Outcomes for non-heart-beating 
donor kidney tx outcome are similar to heart-beating donors for 
the incidence of delayed graft function (50 versus 41%) or 2-year 
FiGURe 1 | 2011–2014 organ transplantation rates in Southeast Asia, patients per million population.
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kidney graft survival (96 versus 98%) (33). Paired kidney donation 
can be undertaken after the last HOTA amendment in 2009 (34). 
The first case was enrolled in the Paired Exchange Registry in 2014 
and operated in early 2015 (34). This program was expected to drive 
the tx rate, but Singapore’s relatively small population is an obstacle 
to finding compatible donor–recipient pairs. Hepatitis B virus 
(HBV)-infected, human immunodeficiency virus-infected patients, 
and alcoholic patients are excluded from tx in Singapore (26).
BRUNei DARUSSALAM
Brunei Darussalam is an Islamic state that has a high HDI similar 
to Singapore (13). Bruneians enjoy support from their govern-
ment, and only 6% of health expenditure comes from personal 
contributions (15).
Organ Access, Legislation, and 
Reimbursement
Dialysis started in Brunei in 1967 and had progressively 
increased to more than 500 active cases at present (35). Organ 
tx became available within the country in 2013, with access only 
to living-related kidney tx. Prior to 2013, eligible ESRD patients 
were screened and matched with available living-related donors 
and sent overseas for tx, under government support (35, 36). 
Despite these efforts, problems exist with transplant tourism. 
The country has no official cell, tissue, and organ tx law (36), and 
tx growth in this region is limited due to poor public awareness, 
cultural concepts about brain death, and poor local transplant 
facilities (36). Nevertheless, the Brunei government is taking 
steps to improve access to health and tx care by increasing subsi-
dies for health-care services (37, 38), and the establishment of 15 
FiGURe 2 | 2000–2013 incidence of treated end-stage renal disease (ESRD) and kidney transplantation rates in Southeast Asia and the US, patients  
per million population.
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national health centers (39). It expands access to primary care, 
with 1.4 physicians per 1,000 people (15) and one nephrologist 
per 136-treated ESRD patients (38). The first Brunei Dialysis and 
Transplant Registry was initiated in 2011 (35, 38) and shows the 
high incidence (265 ppmp) and prevalence (1,289 ppmp) rates 
of ESRD with the predominant cause of ESRD being due to 
diabetes (35, 40).
Tx Outcomes
There have been 49 cases of kidney tx from 1993 to 2012 (36). 
All of them were performed in foreign centers because the local 
tx activity only began in 2013. The 5- and 10-year overall graft 
survival rates are 91.1 and 81.2% (Table 3) with a 10-year patient 
survival rate of 90%, better than similar reports from Malaysia 
(41) and the OPTN (42), likely because this cohort of tx Bruneian 
patients is mostly younger, non-diabetic patients.
MALAYSiA
Malaysia is a multicultural and multi-faith country, consisting 
of Muslims, Buddhists, Christians, and Hindus, with Malay, 
Chinese, and Indian ethnicity (43). It has pursued economic 
growth and reached upper middle income (44). Malaysia has a 
high HDI, above the average Southeastern Asia HDI (13) and it 
spends 4.2% of its GDP in health expenditure (15).
Organ Access, Legislation, and 
Reimbursement
Renal replacement therapy was introduced in Malaysia in 1976 
(45). Malaysia has an active dialysis program, with about 758 
dialysis centers, most (94%) offering hemodialysis (46). Due to 
increased acceptance of dialysis as a mainstay therapy for ESRD in 
Malaysia, the prevalence of dialysis increased from 13,000 in 2005 
to 35,000 in 2014 (46) (Figure 2). Malaysia is a welfare-oriented 
state (47). The Malaysian government is the principal payer of 
renal replacement therapy by a public–private partnership model 
(48, 49), and the government subsidizes both public dialysis 
centers and non-governmental organizations (48) such as the 
National Kidney Foundation. The Private Healthcare Facilities 
and Services Act, enacted in 2006, allowed hemodialysis facilities 
to be set up outside hospitals areas, which resulted in the rapid 
growth of private dialysis units and increased hemodialysis 
access (46, 48, 49). Tx was initially performed in Malaysia in the 
1970s (45). Malaysia provides kidney, liver, and lung tx mostly in 
public medical centers under the National Organ, Tissue, and Cell 
Transplantation Policy, which was enacted in 2007 (50, 51). Organ 
tx programs are overseen by the National Transplant Council (51). 
The National Transplant Procurement Management Unit helps 
with deceased donor allocation and is supported by the local 
Tissue Organ Procurement Team in each donor hospital (51). 
Brain death diagnosis and certification is done under guidance 
from the Brain Death Committee (52). The National Transplant 
Waiting list is managed by The National Transplantation Unit, 
which was established within the Ministry of Health for regulat-
ing financial support and monitoring ethical standards for tx 
(51, 53). Between 2005 and 2014, the kidney tx rates fell by 50%, 
FiGURe 3 | 2014 organ donation and transplantation rate in Southeast Asia and the US, patients per million population.
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from 6 to 3 ppmp (46) due to a reduction in tx tourism, mainly 
in China (47) due in significant part to increased local legislation 
and the Istanbul Declaration (54), which desist organ trafficking. 
Living donation has to be authorized by the Unrelated Transplant 
Approval Committee (51) to limit transplant tourism.
Tx Outcomes
According to the 2014 Malaysian Dialysis and Transplant 
Registry, the overall renal graft survival rates are 93, 88, 83, and 
67% in year 1, 3, 5, and 10, respectively (Table 3) (46). The pri-
mary immunosuppressive regimen used are based on calcineurin 
inhibitor-based therapy with a decreasing use of cyclosporine 
(59% in 2010 to 44% in 2014) and increasing use of tacrolimus 
(32% in 2010 to 45% in 2014). Mycophenolic acid is used for 68% 
of kidney tx as maintenance therapy (55).
THAiLAND
Thailand has a lower HDI than the previous regions and 
spends 6.5% of its GDP on health care (15). 7.9% of Thai 
health expenditure comes from personal contributions (15). 
Physician coverage in Thailand is sparse with 0.4 physicians 
per thousand people (15), much lower than Malaysia (1.2 phy-
sicians per thousand people) or Singapore (2 physicians per 
thousand people), even though the incidence of treated ESRD 
is equivalent (Figure 2).
TABLe 3 | Kidney allograft survival in the major Southeast Asian countries.
Countries Overall kidney allograft 
survival
Transplanted 
year
Reference
1-year 5-year 10-year
Singapore 93.2% 86.6% 69.4% 1999–2006 (31)
Brunei 
Darussalama
NA 91.1% 81.2% 1993–2012 (36)
Malaysia 93% 83% 67% 2005–2014 (46)
Thailandb 96.2% 90.0% 78.9% 2002–2006 (63)
Vietnamc 82% NA NA 2004–2008 (104)
Myanmarc 95% NA NA 1997–2003 (107)
aLiving donor graft from overseas from the national registry.
bDeceased donor graft from the national registry.
cLiving donor graft reported from the single center.
NA, no available data.
TABLe 2 | Health expenditures, financing policies for dialysis, and transplantation in the transplanted Southeast Asian countries.
Countries Populations 
(millions) in 
2015
Total 
spending for 
healthcare 
as % of 
GDP in 
2014a
Out of 
pocket 
payment 
for health 
careb (%)
Prevalence of 
treated end-stage 
renal disease 
(eSRD) cases 
2013, gross 
numbers (8)
Prevalence of 
treated eSRD 
cases 2013, 
per million 
populations (8)
Government policy for  
dialysis costs coverage
Government 
coverage 
for kidney 
transplantation 
costs
Singapore    5.6 4.9 54.8 6,955 1,809.1 Minimal Limited
Brunei 
Darussalam
   0.4 2.6   6.0 NA NA 100% 100%
Malaysia   30.3 4.2 35.3 33,887 1,140.4 58% of HD versus 100% of PD 100%
Thailand   68.0 6.5   7.9 71,037 1,096.6  – PD first policy group: 100% of PD or 
100% of HD if PD contraindicated
 – Other group: 100% of either PD or HD
100%
Philippines 100.7 4.7 53.7 23,727 224.4 90 sessions HD or 360 days PD per year NA
Indonesia 257.6 2.8 46.9 NA 65.9 100% HD or 100% of 3-bags per day PD or 
80% of 4-bags PD
Partial
Vietnam  93.4 7.1 36.8 NA NA 100% of either PD or HD 50%
Myanmar  53.9 2.3 50.7 NA NA None None
aDenotes total health expenditure, which is the sum of public and private health expenditure. It covers the provision of health services (preventive and curative), family planning 
activities, nutrition activities, and emergency aid designated for health but does not include provision of water and sanitation.
bDenotes out of pocket expenditure, which is any direct outlay by households, including gratuities and in-kind payments, to health practitioners and suppliers of pharmaceuticals, 
therapeutic appliances, and other goods and services whose primary intent is to contribute to the restoration or enhancement of the health status of individuals or population 
groups. It is a part of private health expenditure.
PD, peritoneal dialysis; HD, hemodialysis; NA, no available data.
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Organ Access, Legislation, and 
Reimbursement
The growing incidence and prevalence of ESRD (157.8% increase 
from 2007 to 2009), with stable numbers of kidney tx in the 
region (9), has contributed to an expanding kidney tx waiting list 
in Thailand. The Universal Coverage Scheme (UCS) authorized 
by the National Health Security Act enacted in 2002 (56–58), sup-
plemented health-care support (56–59) with expanded coverage 
for renal replacement therapy through the Thai peritoneal dialysis 
(PD) first policy (2007) and kidney tx (9) (Table 2). To date, all 
Thais can get access to dialysis and tx through one of three major 
health schemes in the country, the largest being through UCS 
(9, 60).
The first kidney tx was done in Thailand in 1972 (61, 62). 
Thailand now provides bone marrow, liver, heart, lung, and 
heart and lung transplantations in 26 transplant centers around 
the country (63). Brain death criteria were set up in 1989 and 
revised in 2011 (64). The Organ Donation Center is a non-
for-profit, central organization, established in 1994 under the 
umbrella of the Thai Red Cross Society (64, 65), responsible 
for national waiting lists, centralized deceased donor allocation, 
accreditation of tx centers, with voluntary data reporting from 
tx centers (64). Public organ donation campaigns have been 
supported by the Thai Royal family to increase awareness, organ 
access, and extended coverage for kidney tx (65, 66). Moreover, 
the Organ Donation Center with collaboration from the 
Ministry of Public Health have established full-time transplant 
coordinator teams in 24 referral hospitals to help with organ 
recovery and procurement (67). As a result, the kidney tx rate 
is increasing (Figures 1 and 2).
Tx Outcomes
The renal graft survival and patient survival rates are comparable 
to other registries and have improved significantly over the last 
two decades (63). One-, 5-, and 10-year death-censored renal 
graft survival rates are 95.4, 89.3, and 83.7% for living donor tx 
versus 96.2, 90.0, and 78.9% for deceased donor tx (63). The most 
commonly used immunosuppressive regimen comprises of tac-
rolimus, mycophenolate, and prednisolone that is similar to the 
US. Induction therapy is used for 70.4%; interleukin-2 receptor 
antagonist is the most common induction agent while T-cell-
depleting agents are more common in the US (68). Induction 
therapy is being increasingly used, with 55% use in 2012 to 70.4% 
in 2015 (63, 68, 69). Pediatric kidney tx outcomes reported 1-year 
patient and graft survival rates of 100% either for living donor 
or deceased donor tx, with similar immunosuppressive regimens 
as in adults. One-, 5-, and 10-year graft survival rates are 96.2, 
81.9, and 64.4%, respectively (68). Thailand offers kidney tx for 
HBV- and HCV-positive patients, as well as ABO-incompatible 
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kidney tx in some centers (70). Donation after cardiac death and 
paired kidney exchange program is not available to date.
PHiLiPPiNeS
The Philippines spends 4.7% of GDP for health expenditure, but 
unlike the former countries that have more government support 
(Table 2), Filipinos personally pay for about 53.7% of their health 
expenses (15).
Organ Access, Legislation, and 
Reimbursement
The Philippines have growing rates of ESRD (Figure  2), with 
expanding wait lists as organ donation rates are stagnant with 
deceased donation rate as low as 1  ppmp (Table  1) (71). The 
flat rate is on the grounds of high out-of-pocket in health-care 
costs for dialysis and living kidney tx (72), and a shortage of the 
necessary infrastructure support to enhance organ donation, 
procurement, allocation, and tx (73). The Philippine Health 
Insurance Corporation (PhilHealth) was implemented in 1995, 
but partial coverage for dialysis was only included in an amend-
ment in 2006 (74, 75). In 2012, PhilHealth provided the Z Benefits 
Package covering catastrophic illnesses like malignancies and 
kidney tx, and in 2015, it expanded coverage for hemodialysis 
sessions from 45 to 90 sessions per year, and for PD from 270 to 
360  days per year (76). The Philippines performs kidney, liver, 
pancreas, bone marrow, and islet cell as well as double trans-
plants like liver and kidney or pancreas and kidney (77, 78). The 
Philippine Network for Organ Sharing (PHILNOS), established 
by the Department of Health in 2010, is the central coordinating 
body of all deceased organ or tissue donation and tx activities 
(79, 80) and governs various operational guidelines including the 
brain death protocol, allocation scoring, deceased donor referral, 
waiting lists. The PHILNOS is monitored by the External Audit 
Department with particular emphasis on organ allocation pro-
cedures. The PHILNOS runs the Philippines Organ Donor and 
Recipient Registry System, and the deceased allocation system 
is centralized under the Donor Allocation Scoring System (81). 
The National Transplant Advisory Board, National Transplant 
Ethics Committee, and the Kidney Donor Monitoring Unit, all 
help set tx guidelines (82).
Kidney tx in the Philippines is mostly from living donors 
(94%) (Table 1), from both living-related and unrelated donors; 
with the larger proportion (70.1%) being from unrelated donors 
(83). For related donors, non-immediate family members are 
also eligible donors (73). Donor compensation as “gratitudinal 
gifts” to living unrelated donor is allowed (82). Before 2008, the 
government approved a 10% cap to each tx center to allocate 
living donors from Filipinos to foreigners, in  situations when 
Filipinos recipients were not available (82, 84–86). Unfortunately, 
this resulted in unacceptable rates of organ trafficking such that, 
in 2008, in an effort to eliminate tx tourism, the PHILNOS 
prohibited all tx to foreigners using Filipino organs. The World 
Health Organization identified the Philippines, China, and 
Pakistan as key areas driving organ trafficking (80). With sup-
port from the 2008 Declaration of Istanbul on Organ Trafficking 
and Transplant Tourism, the Philippines government enacted the 
anti-commercialization of human organs, tissues, or part of living 
persons Act of 2008 (86, 87). This Act established the Philippines 
Board for Organ Donation and Transplantation to oversee policy 
implementation and to define penalties by imprisonment and 
fines.
Tx Outcomes
The majority of kidney tx patients in the Philippines are pre-
scribed  tacrolimus, mycophenolate, and prednisone for initial 
immunosuppression. As most of them are living donor recipi-
ents, 99% of recipients received induction therapy with either 
Basiliximab or rabbit anti-thymocyte globulin, and 98% have 
immediate graft function, with minimal or absent rates of delayed 
graft function in most centers (88). Nevertheless, the report of 
graft and patient survival rates from the Philippines are difficult 
to access.
iNDONeSiA
Indonesia is the most populous Muslim-majority in the world 
with the largest economy in Southeast Asia (89). Though the 
government had expanded universal coverage for nearly half of 
population in 2014, Indonesians still pay out-of-pocket for 46.9% 
of health expenditure (Table 2) (15, 90). The little government 
spending in social health security increases the health-care cost 
burden on patients and families (91). This impact is most on the 
poor, who can have limited access to dialysis and tx care.
Organ Access, Legislation, and 
Reimbursement
Hemodialysis was introduced in Indonesia in 1967 and PD in 
1985, but both have progressed slowly due to limited reimburse-
ment (92, 93). After the government initiated health-care reform 
with dialysis coverage in 2005, the number of treated ESRD has 
grown rapidly to ~200 ppmp by 2013 (8). However, detailed data 
on the actual gap between patients needing dialysis and those 
receiving kidney transplants in the region are lacking (48), and 
it seems that up to one-third of ESRD treatment may be self-
funded (30).
The first kidney tx in Indonesia was recorded in 1977 (94). The 
Indonesia 1991 Health Regulation provided for the procurement 
of tissue from living donors, but not from deceased donors (95). 
The Kemayoran Consensus was signed in 1995, which stated 
that all religions in Indonesia accepted the concept of organ tx, 
and human organ commercialization is forbidden (94). In sup-
port of this, the Indonesia Islamic Groups and the Federation of 
the Islamic Medical Association have endorsed the concepts of 
brain death (52). In 2014 (89–91, 96), the government launched 
Indonesia’ universal health coverage/jaminan kesehatan nasional 
(UHC/JKN) to cover 120 million people who are already engaged 
in various social health insurance schemes into the Social Security 
Management Agency for the Health Sector (89). The UHC/JKN 
program has a target to enroll 250 million people by 2019.
For those included in this program, all costs for hemodialysis 
and PD with three continuous ambulatory PD fluid exchanges are 
9Chan-on and Sarwal Kidney Transplantation in Southeast Asia
Frontiers in Medicine | www.frontiersin.org June 2017 | Volume 4 | Article 84
covered by government health insurance (93). Costs for kidney 
tx are also covered partly by government health insurance (97), 
though to date, only 7 from 33 medical centers in the country 
participate for full JKN coverage (90). There are concerns that 
the growth of JKN may be halted by regulation disparities, poor 
health-care infrastructure, and the urban–rural gap in the num-
ber of medical staff (90).
Tx Outcomes
In 2009, three centers in Indonesia performed kidney tx. 
Kidney tx from “emotionally-related” donors and the spouse, 
is accepted in Indonesia (94). Five- and 15-year renal graft 
survival rates are 60 and 50% (94). Immunosuppressive drug 
combinations consist of either cyclosporine A, azathioprine, 
and corticosteroids or tacrolimus, mycophenolate mofetil, and 
corticosteroids (97).
vieTNAM
Vietnam has enjoyed rapid economic growth with a dramatic 
reduction in poverty over the last decade (98). Social and health-
care outcomes have improved significantly (98). In 2014, the 
Vietnamese government spent 7.1% of its GDP on health care and 
Vietnamese personally pay for ~36.8% of health-care expenditure 
(Table 2) (15).
Organ Access, Legislation, and 
Reimbursement
Major economic reforms have been introduced in Vietnam 
including the introduction of social health insurance and per-
mission for private sectors in health care. Dialysis was included 
in insurance coverage with erythropoietin therapy in 2005, and 
~50% of tx therapy is covered (99–101). Increasing numbers 
of patients receive hemodialysis and PD in Vietnam, and it 
is estimated that the prevalence of treated ESRD is more than 
120 ppmp (100). The first kidney tx was performed successfully 
in Vietnam in 1992 (99), and currently, Vietnam also performs 
liver and heart transplants. Before 2006, only living-related organ 
tx were allowed. The Vietnamese government passed a law in 
2006 for regulation of living and deceased organ donation, the 
organization of tissue banks, the establishment of the National 
Coordination Center for Human Organ Transplantation, and 
decreeing prohibiting of organ commercialization (99, 102). 
The law provided living donor compensation such as free health 
insurance cards, free regular health check, and to get prioritized 
tx themselves. It also addressed brain death criteria, diagnostic 
protocols, and the establishment of tx centers. Living donors had 
to have the same bloodline with the recipient or were required to 
be the next of kin within three generations of the recipient. The 
law also allowed Vietnamese in going abroad for donating organs 
to their relatives or vice  versa (102). Unrelated living donors, 
namely, husbands or wives or friends were acceptable donors.
The National Coordination Center for Human Organ 
Transplantation is responsible for organizing donated body tissue 
and organs and will cooperate with tissue banks and hospitals 
nationwide. To date, ~400 living donor kidney and liver txs and 
~10 deceased donor txs have been done in Vietnam. Thirteen 
health-care facilities meet the regulations and conditions for 
carrying out body tissue and organ txs in Vietnam (103). The 
deceased donor organ tx program still faces impediments and 
suggested improvements to the system are to set up a national 
online database system and increased public education on 
deceased donor donation.
Tx Outcomes
Single center data show that 1- and 3-year renal graft survival is 82 
and 65% from living donors, with 1- and 3-year patient survival 
at 82 and 73%, respectively (Table 3) (104). Immunosuppression 
usage consists of anti-interleukin-2 receptor monoclonal anti-
body induction and triple drug regimen as maintenance therapy 
with cyclosporine or tacrolimus, mycophenolate mofetil or 
mycophenolic acid sodium, and corticosteroids.
MYANMAR
Organ Access, Legislation, and 
Reimbursement
There is the lack of government health-care payment for chronic 
disease care like dialysis or tx in Myanmar (105). Burmese 
patients support high out-of-pocket costs to the tune of 50% of 
their health-care expenditures (Table  2) (15). Recently, a trial 
prepaid health insurance system was started in July 2015 with 
cooperation from national and international non-governmental 
organizations (106).
The first kidney tx in Burma was done in 1997 (107). Only 
two hospitals in Myanmar perform kidney txs—Yangon General 
Hospital and Mingalardon Military Hospital (108). Due to a lack 
of sufficient infrastructure to support tx needs for all patients with 
ESRD in Myanmar, many private-pay-patients get their tx in India 
(109). The government promulgated the Body Organ Donation 
Law in 2004, which allows deceased organ donation and living-
related organ donation within immediate family members (108, 
110). This law sets heavy penalties for organ commercialization 
by imprisonment for up to 3 years.
Tx Outcomes
There are limited sources of information to find out the number 
and clinical outcome of tx activities in Myanmar. However, there 
is a single-center report of 21 living-related donor kidney tx with 
95% 1-year- and 91% 6-year-graft survival rates (Table 3) (107).
LAOS, CAMBODiA, AND TiMOR-LeSTe
Cambodia has at least 10 hemodialysis units available for ~200 
patients, but patients have to cover 100% of costs as there is no 
government subsidy (111). To date, there are no significant tx 
activities in Laos, Cambodia, and Timor-Leste, and patients have 
to go overseas for tx.
There is a growing demand for organ tx in Southeast Asia, 
which is currently not being met due to various reasons that 
range from access, infrastructure, economics, and legislation. 
The unmet need is evident, but ESRD disease epidemiology 
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and prevalence can be difficult to assess in some countries in 
Southeast Asia due to a lack of standardized national registry 
data. Improved access to tx will also require increased procedure 
affordability by transitioning health-care financing away from 
the patient and toward national coverage (9). The WHO Madrid 
consultation (10, 112) in 2010 proposed a 1–5 tier system (with 
5 being the highest) for ranking the capabilities of regional tx 
services. Three of the 11 Southeast Asian countries are at level 
1 (Laos, Cambodia, and Timor-Leste). Thailand and Singapore 
were reported to have level 4 services, Malaysia, the Philippines, 
and Vietnam have level three services, and Indonesia and 
Myanmar showed having level 2.
SUGGeSTeD STRATeGieS FOR 
iNCReASiNG TX iN SOUTHeAST ASiA
A review of the regions above suggests that improved access and 
outcomes for ESRD and tx will require attention to the following 
prime factors.
Developing a Framework to increase 
Deceased Donation
There are two deceased donor structures in the Southeast Asia, 
i.e., the opting-in system based on informed consent, and the 
opting-out system based on presumed consent. Singapore 
is the only state in the region that has the opting-out scheme. 
Enrollment for the opting-in scheme is hampered in regions that 
have low rates of available physicians and trained coordinators, 
and high clinical services workload can lead to less time for com-
munication. A priori consent at information repository centers 
such as driver licensing registration or tax-return registration can 
improve donor organ access.
Southeast Asia has a high incidence of deaths from fatalities 
involving stroke and road traffic accidents. In fact, Thailand ranks 
second in the world for traffic fatalities with a mortality rate of 
36.2 patients per 100,000 population (113) and fatality from 
stroke is the most common cause of death in Thailand with more 
than 250,000 new cases and 50,000 lives claimed annually (114). 
Thus, there can be a high volume of eligible brain death donors. 
Legislation to support the diagnosis of brain death and optimal 
support from transplant coordinator teams is crucial to increase 
the deceased donation rate in this region. Another measure to 
expand the donor pool is to enable the use of non-heart-beating 
donors as outcomes for kidney grafts are comparable to trans-
plants from brain dead donors in the US and Singapore (33, 
115). Education of professionals with organ reperfusion skills to 
maintain these organs is also needed in the ICUs in these regions 
(115–117).
increased Access to Living Donors
Increased rates of living donation can be accomplished by 
inclusion of unrelated donors, namely emotionally related 
donors, such as a spouse, friend, in-law, stepparent, adoptive 
children, friend, or even an altruistic stranger (118, 119). But 
concerns lie in this region that expanding the criteria for accept-
able living donors can adversely impact organ commercialism 
(73, 84, 120). Southeast Asian countries allow living dona-
tion from a spouse included Malaysia, Thailand, Philippines, 
Indonesia, and Vietnam. In Myanmar, only immediate family 
members are authorized to donate.
Donor Compensation—The Sticky wicket
Donor “compensation” is interpreted as donor “incentives” by 
some. The term “incentive” refers to all forms of material gain 
or similar advantage offered for consent to living donation or 
authorization of deceased donation of organs (121). The term 
“compensation” refers to payment for the costs incurred around 
tx that would cause the donor financial hardships and would 
include activities such as traveling and accommodation costs and 
lost wages (122–124). In the US, National Organ Transplant Act 
has allowed for financial compensation for the necessary expenses 
incurred by the donor of a human organ (125). In 2004, the 
Organ Donation and Recovery Improvement Act was launched 
to enable funding for an organ donation awareness program and 
public education as well as funding for donor compensation 
(126). The National Living Donor Assistance Center approves 
of grants to pay for travel and subsistence expense for some 
living donors who have financial hardship (125). In countries 
without universal health care, prospective donors might not have 
insurance to cover following complications or even to pay for 
a routine check-up. Often, potential donors are also concerned 
that donation might restrict their hiring opportunities (127). The 
Philippines program has allowed gifts based on gratitude, sup-
porting compensation for health and life insurance, lost income, 
and education (82, 84). Regulated compensation can provide a 
rational, accessible, and equitable donor allocation program (82). 
Aside from financial compensation, non-financial support for 
the donor can come in the form of community recognition that 
is a valuable commodity in Asia. Saudi Arabia offers donors “the 
King Abdul Aziz medal” as well as a discount card with Saudi 
Airlines (128).
Management of the National Registry, 
waiting Lists, and Central Allocation
Professional organizations such as the nephrology societies in each 
region should support national registries; the Singapore Renal 
Registry, the Malaysian National Renal Registry, and Thailand 
Renal Replacement Therapy Registry are three such registries in 
the area. A centralization of deceased organ allocation will ensure 
equity of allocation and get the best match.
Health Financing System
We think that health-care reform can help increase end-stage 
organ disease access to treatment and tx activities in this region. 
Aside from Medicare and Medicaid that enacted since 1965, 
Americans have abided by the Patient Protection and Affordable 
Care Act that passed in 2010 (129). The last law mandates 
that persons over the age of 18 obtain health insurance, either 
through their employer or public insurance program in case they 
cannot afford insurance otherwise. Having a reliable funding for 
health care is mandated to improve access to renal replacement 
therapies.
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education
The tx workforce in Asia is very limited (130). Without strategic 
planning to improve the number of well-trained specialists, the 
delivery of care to patients with end-organ failure or tx will be 
threatened (130). Education of the population is also critical, 
especially in a region with many religious, cultural, and social 
traditions, which can create barriers to organ donation (131, 
132). The drive for altruistic donation in the community requires 
continued public awareness and public education.
In conclusion, there is recognition of the growing burden of 
end-stage organ failure in Southeast Asia. The gap between the tx 
waiting lists and available organs for tx is expanding.
Improved legislation, health-care reform, and education are 
key drivers to improve donor availability. National registries are 
urgently needed in the entire region to review and improve tx access 
and outcomes. Continued heightened surveillance to support legal 
practices in organ harvesting and donation and strict laws to curb 
transplant commercialization and tourism are necessary to have in 
place and enforce. With these practices in place, the next decade will 
likely show rapid advances in access to state of the art medical man-
agement for renal failure and renal tx, with a significant impact on 
improving population mortality and morbidity in Southeast Asia.
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